Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bangalore 560054, Karnataka, India.
SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V.L. Mehta Road, Vile Parle (West), Mumbai 400056, Maharashtra, India.
Anticancer Agents Med Chem. 2020;20(6):678-686. doi: 10.2174/1871520620666200227091811.
Cancer is one of the prominent global causes of death and the foremost worldwide health concern. Despite unprecedented progress in cancer chemoprevention, a vast number of cancers, however, remain an undefeatable challenge for treatment modalities. Immense therapeutic activities of puerarin contribute to its use in various health disorders. In this review, we explored the potential molecular mechanisms and targets of puerarin, proving its potential as a novel anticancer agent, for future cancer therapy and chemoprevention. Several mechanisms account for anticancer activity of puerarin which includes downregulation of NF-kB signalling pathway, mTOR signalling pathway, PI3K and BCl-2 proteins and upregulation of miR-16, caspase proteins, c- Jun N terminal kinase and extracellular signal-regulated kinase 1/2. These alterations result in inhibition of cancer cell proliferation and/or induction of apoptosis. Understanding the molecular mechanisms involved in chemotherapy and chemoprevention could aid in the more pronounced exploration of puerarin in effective cancer treatment.
癌症是全球主要死亡原因之一,也是全世界首要的健康关注点。尽管在癌症化学预防方面取得了前所未有的进展,但仍有大量癌症是治疗方法无法攻克的挑战。葛根素具有巨大的治疗作用,因此被用于多种健康疾病的治疗。在这篇综述中,我们探讨了葛根素的潜在分子机制和靶点,证明了其作为一种新型抗癌药物的潜力,可用于未来的癌症治疗和化学预防。葛根素的抗癌活性有几种机制,包括下调 NF-κB 信号通路、mTOR 信号通路、PI3K 和 BCl-2 蛋白,以及上调 miR-16、半胱天冬酶蛋白、c-Jun N 末端激酶和细胞外信号调节激酶 1/2。这些变化导致癌细胞增殖受到抑制和/或诱导细胞凋亡。了解化疗和化学预防中涉及的分子机制可能有助于更深入地研究葛根素在有效癌症治疗中的作用。